Hospital
O'connor Hospital
O'connor Hospital was paid $3.12M by Medicaid between Jan 2018 and Feb 2019, across 129 billing codes. Its largest line is 0450, Emergency room services — 29% of everything it billed.
33Billing provider infoO'CONNOR HOSPITAL
SAN JOSE, CA 95128
SAN JOSE, CA 95128
33aNPI1649381682assigned 08/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.12M
24GClaims109,875
24DCodes billed129
24AFirst – last monthJan 2018 – Feb 2019
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#241 of 410
Median peer was paid$6.90M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 93,069 | $2.68M | |
| 2019 | 16,806 | $433K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 29% | 7,381 | 6,777 | $901K |
| 80053 | Comprehensive metabolic panel | 12% | 5,398 | 5,004 | $389K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 9.7% | 1,375 | 781 | $303K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.1% | 4,883 | 4,595 | $221K |
| Z7502 | 6.0% | 5,012 | 4,988 | $186K | |
| J3490 | Unclassified drugs | 3.8% | 7,138 | 3,569 | $119K |
| 71046 | Radiologic examination, chest; 2 views | 2.5% | 1,592 | 1,505 | $79K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.5% | 745 | 726 | $78K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 1,072 | 970 | $77K |
| 87081 | 1.6% | 501 | 482 | $50K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.5% | 1,056 | 1,002 | $46K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.3% | 2,752 | 2,405 | $40K |
117 more codes
| 87420 | 1.3% | 291 | $39K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.2% | 280 | $38K |
| Z7610 | <1% | 2,317 | $28K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 731 | $25K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,555 | $24K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 707 | $24K |
| 81001 | <1% | 5,059 | $23K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,477 | $19K |
| 71020 | <1% | 126 | $19K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,096 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,111 | $17K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,068 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,461 | $15K |
| 73610 | <1% | 139 | $14K | |
| 99285 | Emergency room visit (most serious) | <1% | 754 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,351 | $13K |
| 0710 | <1% | 536 | $13K | |
| 73030 | <1% | 126 | $13K | |
| 71045 | Radiologic examination, chest; single view | <1% | 875 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,379 | $12K |
| 0250 | <1% | 1,143 | $12K | |
| 73564 | <1% | 143 | $12K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,559 | $11K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 532 | $10K |
| 73630 | <1% | 162 | $10K | |
| 99284 | Emergency room visit (serious) | <1% | 2,545 | $10K |
| 84702 | <1% | 695 | $9K | |
| Z9725 | <1% | 201 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 285 | $9K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 667 | $8K |
| 74018 | <1% | 87 | $7K | |
| 80306 | <1% | 514 | $6K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 268 | $6K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 197 | $6K |
| 84484 | <1% | 1,521 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 17 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 244 | $5K |
| 72100 | <1% | 85 | $5K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 82 | $5K |
| 72040 | <1% | 28 | $4K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 323 | $4K |
| 86850 | <1% | 48 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 423 | $3K |
| 83735 | <1% | 866 | $3K | |
| 83880 | <1% | 496 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 487 | $3K |
| 0272 | <1% | 548 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 252 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 268 | $3K |
| 81025 | <1% | 1,838 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 548 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 528 | $2K |
| 82962 | <1% | 693 | $2K | |
| 82553 | <1% | 765 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 60 | $2K |
| 96367 | <1% | 73 | $2K | |
| 94644 | <1% | 106 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,462 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 676 | $2K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 86 | $2K |
| 80061 | Lipid panel | <1% | 67 | $2K |
| 87040 | <1% | 372 | $1K | |
| 82550 | <1% | 796 | $1K | |
| 85730 | <1% | 983 | $1K | |
| 87077 | <1% | 373 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 411 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 61 | $1K |
| 73130 | <1% | 33 | $1K | |
| 83690 | <1% | 1,932 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $931.78 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 60 | $884.97 |
| 88342 | <1% | 32 | $813.90 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 413 | $809.33 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,108 | $791.47 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 117 | $783.66 |
| 85379 | <1% | 191 | $752.11 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 222 | $615.75 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 222 | $615.07 |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $583.68 |
| 0762 | <1% | 30 | $578.53 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 17 | $433.87 |
| 85610 | <1% | 1,375 | $430.77 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 474 | $420.35 |
| 87186 | <1% | 335 | $416.70 | |
| 76801 | <1% | 48 | $416.42 | |
| 73502 | <1% | 12 | $401.04 | |
| 83605 | <1% | 405 | $346.70 | |
| 90715 | <1% | 116 | $345.02 | |
| 81003 | <1% | 573 | $328.25 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 78 | $305.94 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 675 | $277.17 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 448 | $265.40 |
| 86900 | <1% | 313 | $234.15 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $233.66 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 17 | $226.10 |
| 86901 | <1% | 313 | $218.02 | |
| 82950 | <1% | 36 | $191.00 | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 12 | $145.20 |
| 0270 | <1% | 539 | $92.76 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 115 | $87.44 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12 | $86.50 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 169 | $31.39 |
| 86140 | <1% | 92 | $31.16 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 12 | $29.37 |
| 85027 | <1% | 29 | $26.69 | |
| 82150 | <1% | 37 | $26.09 | |
| 87210 | <1% | 44 | $10.36 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $8.92 |
| A9270 | Non-covered item or service | <1% | 3,356 | $3.30 |
| 0258 | <1% | 35 | $3.16 | |
| G0378 | Hospital observation service, per hour | 0% | 178 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 502 | $0.00 |
| 96376 | 0% | 103 | $0.00 | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 0% | 12 | $0.00 |
| 93971 | 0% | 15 | $0.00 | |
| 73110 | 0% | 13 | $0.00 | |
| 71010 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHERGET, JORDAN (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| Saint Louise Regional Hospital | Gilroy, CA | $1.60M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.